Strategic Advocates’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172K Sell
374
-6,742
-95% -$3.41M 0.76% 29
2025
Q4
$4.07M Buy
7,116
+550
+8% +$293K 1.04% 20
2025
Q3
$2.94M Sell
6,566
-504
-7% -$242K 0.76% 23
2025
Q2
$3.84M Buy
7,070
+182
+3% +$95.2K 1.14% 18
2025
Q1
$3.41M Sell
6,888
-905
-12% -$500K 1.19% 17
2024
Q4
$4.07M Sell
7,793
-1,337
-15% -$696K 1.37% 17
2024
Q3
$4.49M Sell
9,130
-883
-9% -$411K 1.61% 13
2024
Q2
$4.45M Buy
10,013
+184
+2% +$73.3K 1.77% 13
2024
Q1
$3.92M Buy
9,829
+2,032
+26% +$768K 1.51% 13
2023
Q4
$2.63M Buy
7,797
+495
+7% +$148K 1.12% 21
2023
Q3
$2.13M Buy
+7,302
New +$2.28M 1% 19

Other funds holding ISRG

Strategic Advocates's ISRG Position: Q1 2026 in Review

Strategic Advocates reduced its Intuitive Surgical (ISRG) stake by 95% in Q1 2026, selling an estimated $3.41M and leaving 374 shares worth $172K. The position accounts for 0.76% of the portfolio, ranked #29.

Strategic Advocates first reported a position in ISRG in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.49M in Q3 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Strategic Advocates held 374 shares of Intuitive Surgical worth $172K as of Q1 2026.
  • Strategic Advocates sold 6,742 Intuitive Surgical shares in Q1 2026, an estimated $3.41M.
  • Intuitive Surgical made up 0.76% of Strategic Advocates's portfolio in Q1 2026, its #29 holding.
  • Strategic Advocates first reported a position in Intuitive Surgical in Q3 2023 and has held it in 11 quarters since.
  • Strategic Advocates's Intuitive Surgical position peaked at $4.49M in Q3 2024.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.